分析
Generate Biomedicines 成功的 IPO,融资 4 亿美元,标志着 AI 驱动药物发现领域的一个重要里程碑。这一成就凸显了生成式人工智能在彻底改变药物研发领域的巨大潜力。这种创新方法有望加速新型蛋白质疗法的开发。
关于ai drug discovery的新闻、研究和更新。由AI引擎自动整理。
"Lots of companies have also deprecated their internally built solution to switch over, dealing with GPU infra and onboarding docker containers not being a very exciting problem when the company you work for is trying to cure cancer."